This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Database I: Genetic Tests for Cancer: Database of genetic tests currently available
Return to Contents
1. Test (by type of test)
| Name |
Other Names |
Primary Prevention |
Secondary Prevention |
Diagnostic |
Prognostic |
Recurrence |
Monitoring |
Specimen |
| Acid phosphatase, total and prostatic |
PAP |
|
|
|
x |
x |
x |
serum |
| Adrenocorticotropic hormone |
ACTH |
|
|
x |
|
|
|
plasma |
| Alpha fetoprotein |
AFP |
|
x |
|
x |
x |
x |
serum |
| AML1/ETO translocation |
t(8;21) |
|
|
x |
x |
x |
x |
blood, marrow |
| B-cell gene rearrangement |
|
|
|
x |
x |
x |
|
blood, marrow, tissue |
| BCL-1/JH gene rearrangement |
t(11;14) |
|
|
x |
x |
|
x |
blood, marrow, tissue |
| BCL-2 translocation |
t(14;18) |
|
|
x |
x |
x |
x |
blood, marrow, tissue |
| BCR/ABL gene rearrangement |
Philadelphia chromosome |
|
|
x |
x |
x |
x |
blood, marrow |
| Beta human chorionic gonadotropin |
b-HCG |
|
|
x |
|
x |
x |
serum |
| Beta-2 microglobulin |
|
|
|
x |
x |
|
|
serum |
| Bladder tumor antigen |
BTA |
|
|
|
|
x |
x |
urine |
| BRCA Analysis |
BRCA1, BRCA2 |
x |
|
|
x |
|
|
blood |
| Calcitonin |
|
|
x |
x |
x |
x |
|
serum |
| Cancer antigen 125 |
CA 125 |
|
|
|
|
x |
x |
serum |
| Cancer antigen 15-3 |
CA 15-3 |
|
|
|
|
x |
x |
serum |
| Cancer antigen 19-9 |
CA 19-9 |
|
|
|
|
x |
x |
serum |
| Cancer antigen 27.29 |
CA 27.29 |
|
|
|
|
x |
x |
serum |
| Carcinoembryonic antigen |
CEA |
|
x |
|
x |
x |
x |
serum |
| Cathepsin D |
|
|
|
|
x |
|
|
tissue |
| CBFB/MYH11 fusion protein |
inv(16), t(16;16) |
|
|
x |
x |
|
x |
blood, marrow |
| CD 117, c-kit |
Gleevec sensitivity |
|
|
x |
|
|
|
tissue |
| CD 20 |
Rituxan sensitivity |
|
|
x |
|
|
|
blood |
| CD 25 |
Ontak sensitivity |
|
|
x |
|
|
|
Blood, marrow, tissue |
| CD 33 |
Mylotarg sensitivity |
|
|
x |
|
|
|
Blood, marrow |
| CD 52 |
Campath sensitivity |
|
|
x |
|
|
|
Blood, marrow |
| Chromosome 18q assay |
18q/RER, DCC |
|
|
x |
x |
|
|
Blood, tissue |
| Colaris |
MLH1, MSH2 |
|
x |
x |
|
|
|
Blood |
| Colaris AP |
APC, FAP |
|
x |
x |
|
|
|
Blood |
| Cyclin-D1 |
|
|
|
x |
x |
|
|
Tissue |
| E-cadherin |
|
|
|
|
x |
|
|
Tissue |
| Epidermal growth factor receptor |
EGFR pharmDx, HER-1, Erbitux sensitivity |
|
|
x |
|
|
|
Tissue |
| Estrogen/progesterone receptor |
ER/PR |
|
|
x |
x |
|
|
Tissue |
| Fecal globin |
InSure, FOBT |
|
x |
|
|
|
|
Stool |
| FLT 3 mutation |
|
|
|
|
x |
|
|
Blood |
| HER-2/neu |
c-erbB-2, PathVysion, Herceptin eligibility |
|
|
x |
x |
|
|
Tissue |
| 5-HIAA |
5-hydroxyindoleacetic acid |
|
|
x |
x |
|
|
Urine |
| Human papillomavius hybrid capture |
HPV, ThinPrep |
|
x |
|
|
|
|
Pap smear |
| IgVH mutation analysis |
|
|
|
|
x |
|
|
Blood, marrow |
| Immunocyt |
mucin, CEA |
|
|
|
|
x |
x |
Urine |
| Kappa/lambda light chain |
|
|
|
|
|
|
x |
Blood, tissue |
| LAP |
leukocyte alkaline phosphatase |
|
|
x |
|
|
x |
Blood, marrow |
| Lipid associated sialic acid |
LASA, LSA |
|
|
|
|
x |
x |
Serum |
| Melaris |
p16 |
x |
|
|
|
|
|
Blood |
| MIB-1 antibody |
Ki-67 antigen |
|
|
|
x |
|
|
Tissue |
| Micrometastasis detection |
cytokeratins |
|
|
|
|
x |
x |
Marrow, tissue |
| Microsatellite instability |
MSI, BAT-26, RER+, HNPCC |
x |
x |
x |
x |
|
|
Blood, tissue |
| MLH1, MSH2, MSH6 mutations |
HNPCC mismatch repair gene |
x |
|
|
|
|
|
Blood |
| Neuron specific enolase |
NSE |
|
|
|
|
|
x |
Serum |
| Nuclear matrix proteins |
NMP 22 |
|
|
x |
|
x |
x |
Urine |
| Oncotype Dx |
Breast cancer assay |
|
|
|
x |
|
|
Tissue |
| p53 tumor suppressor gene |
p53 |
|
|
|
x |
|
|
Tissue |
| PML/RARA translocation |
t(15;17) |
|
|
x |
x |
|
x |
Blood, marrow |
| PreGen-26 |
MSI, BAT-26 |
x |
x |
|
|
|
x |
Stool |
| PreGen-Plus |
k-ras, APC, p53 |
|
x |
|
|
|
x |
Stool |
| Prostate-specific antigen |
PSA free, total, ultrasensitive, HAMA |
|
x |
|
x |
x |
x |
Blood |
| T-cell recepter gene rearrangment |
|
|
|
x |
|
|
|
Blood, marrow, tissue |
| TEL/AML1 gene fusion |
t(12;21) |
|
|
x |
x |
|
x |
Blood, marrow |
| Thyroglobulin |
|
|
|
|
|
x |
x |
Serum |
| Tumor antigen 90 immune complex |
TA90-IC |
|
|
|
x |
x |
x |
Serum |
| Urokinase plasminogen activator |
uPA, PAI-1 (plasminogen activitor inhibitor) |
|
|
|
x |
|
|
Tissue |
| Urovysion |
Vysis Urovysion |
|
|
|
|
x |
|
Urine |
| ZAP-70 |
|
|
|
|
x |
|
|
Blood, marrow |
Return to Contents
Proceed to Next Section
|
5600 Fishers Lane Rockville, MD 20857